Dana dhuwit diétung saben saham Moderna, Inc. (MRNA)

Lambang korporat lan logo Moderna Therapeutics (MRNA)

Moderna, Inc. (MRNA) is a biotech leader utilizing a unique mRNA platform for the rapid development of vaccines and oncology drugs. The cash per share metric confirms financial stability, where the 12.82 level records fresh values. Powerful research centers in Europe and the US ensure production stability, while its status as a strategic asset for US national security minimizes geopolitical risks.

Dana dhuwit saben saham: Moderna, Inc. (MRNA) kanggo 04.07.2022 - 20.11.2026

Rincian metrik komprehensif lan analitis Moderna Therapeutics (MRNA)

- rega saiki lan proyeksi nilai saham:
- rincian posisi dhuwit lan arus kas:
Analisis komprehensif perusahaan:Moderna Therapeutics - MRNA
Sampel barang Moderna Corp

During the transformation of the Moderna, Inc. (MRNA) product portfolio and the rollout of new mRNA vaccines, this indicator captures the share of liquid assets per common share. The calculation, derived by dividing total cash holdings by the number of issued shares, determines a fundamental defensive barrier, which, in terms of cash position per share, allows the investor to assess the real financial stability of the company beyond speculative noise.